Noninferiority study evaluating dexamethasone (DEX)-sparing regimens administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) caused by high-dose cisplatin.

Luigi Celio,Erminio Bonizzoni,Emilio Bria

Noninferiority study evaluating dexamethasone (DEX)-sparing regimens administered with NEPA, a fixed combination of netupitant and palonosetron, for the prevention of chemotherapy-induced nausea and vomiting (CINV) caused by high-dose cisplatin.

2021

Luigi Celio
Erminio Bonizzoni
Emilio Bria

12093Background: Corticosteroids such as DEX continue to play a key role for the prevention of CINV. Although they are generally considered safe when used in combination with other anti-emetic agen...

Keywords:

Dexamethasone
Palonosetron
Pharmacology
Medicine
Chemotherapy-induced nausea and vomiting
Netupitant
Cisplatin

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations